• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'

    Discussing Matters of Substance in Medtech Materials

    Medical Device Testers Are Caught Up in a Whirlwind

    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    First European Use of CairnSurgical's Breast Cancer Locator System

    Healthcare AI Specialist, SensorsCall Join Forces on Home Monitoring Tech

    Victoria Carr-Brendel Joins Vicarious Surgical Board

    Cognito Therapeutics raises $73M in Series B Funding for Alzheimer’s Treatment

    Ancora Heart's AccuCinch System Shows Promising Results in Heart Failure Patients
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'

    Discussing Matters of Substance in Medtech Materials

    Medical Device Testers Are Caught Up in a Whirlwind

    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    CR-SOP Neurotechnology Helps to Achieve ‘Sound’ Sleep

    Inside the Hospital Value Analysis Committee

    Face Time: Why Getting Engineers Out of the Lab Is Good for Business

    Common Paratubing Pitfalls and How to Avoid Them

    During Times of Uncertainty, Create Business Value with an Optimized Workforce
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    Fusion Biotec Inc.

    Cirtec Medical

    Medbio LLC

    NDH Medical Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing Medical Devices Revolutionized Manufacturing

    5 Current Trends in Medical Device Security

    How Advanced Sensors Improve Design & Functionality of Respiratory Care Equipment

    Sourcing Silicone Parts: Injection Mold or 3D Print?

    Cybersecurity in Healthcare: Getting on the Right Track
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    Fusion Biotec Inc.

    Cirtec Medical

    Medbio LLC

    NDH Medical Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Theranos: Not Long for the Business World?

    ...

    Theranos: Not Long for the Business World?
    Elizabeth Holmes, the chief executive officer and founder of Theranos, at a Palo Alto, Calif. event in 2013. (DoD photo by Glenn Fawcett/Released)
    Michael Barbella, Managing Editor05.03.18
    It won’t be long now.

    With a skeleton staff, dwindling finances, a sullied reputation, and a disgraced leader under criminal investigation, embattled blood testing firm Theranos Inc. seems veritably destined for a terrible, miserable, no good, very sad ending.

    In mid-April, The Wall Street Journal reported the company furloughed most of its remaining workforce in a desperate attempt to stave off bankruptcy, leaving roughly two dozen employees (at most) to run the business. The downsizing is the latest setback in a series of damning headlines, U.S. government probes, and failed pivots that have precipitated the firm’s self-implosion over the last few years.

    The most recent round of layoffs occurred in the wake of fraud allegations against Theranos CEO Elizabeth Holmes and former president Ramesh “Sunny” Balwani. A U.S. Securities and Exchange Commission (SEC) complaint filed on March 14 accuses the pair of misleading investors by raising more than $700 million through “exaggerated or false statements” about the company’s technology and financial performance. Holmes quickly settled with the SEC without admitting any wrongdoing, agreeing to pay a $500,000 penalty; surrender most of her Theranos stock; and accept a decade-long ban on corporate board service. Theranos’ independent directors released a brief statement when the settlement was announced, declaring, “The company is pleased to bring this matter to a close and looks forward to advancing its technology.”

    Balwani, contrarily, is fighting the SEC charges. He became company president in 2009 after guaranteeing a line of credit for the financially struggling Holmes, according to the SEC complaint.

    Theranos’ fairy tale-like existence began to unravel in October 2015 with a Journal expose that questioned the authenticity of the company’s proprietary technology, an iMedicine vision, of sorts, for blood testing. Its miniLab blood analyzer (the size of a desktop computer) purportedly could run hundreds of different diagnostic tests on just a few drops of blood, thereby eliminating the need for long needles and multiple vials. Holmes boasted that the technology would be “faster, cheaper, and more accurate” than alternatives, and claimed the U.S. Department of Defense had used the tests on Afghanistan battlefields. Neither assertion was true though, the SEC contends.

    The deception, however, extended beyond the corner office: The SEC charges that Theranos employees wrote flattering reports about the firm’s own products and affixed pharmaceutical company logos to them to make it appear as if the drugmakers endorsed Theranos’ technology.

    One of the most flagrant examples of Theranos’ deceit involved claims the blood analyzer could process more than 1,000 Current Procedural Terminology codes and that Theranos had developed a technological solution for an additional 300 codes. “But Theranos’ analyzers never performed comprehensive testing or processed 1,000 CPT codes in its clinical lab,” the SEC countered in its complaint. “In fact, as far as Holmes knew, or was reckless in not knowing, Theranos’ clinical lab used the TSPU [Theranos Sample Processing Unit] only to perform 12 of the tests offered to patients.”

    Since its exposure as a fraud, Theranos has voided nearly 1 million blood test results in Arizona and California, and shut two laboratories where its blood analyzers were producing unreliable data. Late last year, the company secured a $100 million loan from private equity firm Fortress Investment Group LLC but received only $65 million up front, the Journal reported.

    To access the rest of the funding, Theranos must meet certain product and operational milestones, including obtaining U.S. Food and Drug Administration approval for a Zika blood test. Such approval could prove difficult, however, due to unreliable test results.

    The layoffs announced last month should keep Theranos afloat through July, but Holmes is hoping to secure the company’s long-term future with additional investments. In an April 10 email detailed by the Journal, Holmes appealed to investors for additional funding, offering to sell a large stake of the firm at a favorable price. She may have trouble, though, finding financiers who are willing to forgive (and forget) her past sins so quickly.

    “If what she’s been charged with is true, she’s a criminal who should be in prison,” one tech investor told Vanity Fair in March. “I highly doubt Elizabeth Holmes set out to be a fraud—much in the same way that I don’t think Bernie Madoff’s business plan from day one was to run a Ponzi scheme. Does that even matter? All founders are faced with difficult choices, and the vast majority of them make the right call, erring on the side of transparency and honesty. To dismiss her wrongdoing is to discount all the founders who, knowing they had the wrong answer for an investor, made the hard choice to tell the truth, knowing it might be the final nail for their company.”

    Some venture capitalists blamed Theranos’ downfall partly on a business model that “encourages” companies to raise massive amounts of money without ever developing a product or proving market need. One investor even faulted the stockholders themselves.

    “It’s on her [Holmes], it’s on the company, it’s on the investors, and the board members who didn’t ask any of the right questions,” one Silicon Valley financier noted to Vanity Fair. “Or, evidently, any questions at all.”  
    Related Searches
    • 2015
    • pharmaceutical
    • blood
    • technology
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    Private Equity Group to Buy Medline for Over $30B Private Equity Group to Buy Medline for Over $30B
    Imec Developing Five Minute COVID Test Imec Developing Five Minute COVID Test
    Abbott Abbott
    Medical Devices and the Political Climate of 2018: An Update from the Swamp Medical Devices and the Political Climate of 2018: An Update from the Swamp
    Medtech M&A Off to a Strong Start in 2018 Medtech M&A Off to a Strong Start in 2018
    LivaNova Clinical Study to Evaluate Treatment Outcomes for Microburst VNS Therapy System LivaNova Clinical Study to Evaluate Treatment Outcomes for Microburst VNS Therapy System
    Software Validation: How It Should Be Done Software Validation: How It Should Be Done
    FDA FDA's Expansion of 510(k) Program Seeks to End Predicate Testing for Some Devices
    Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating
    Theranos’ Holmes and Former President Balwani Charged with Massive Fraud Theranos’ Holmes and Former President Balwani Charged with Massive Fraud
    AtriCure Names Board Chairman AtriCure Names Board Chairman
    FDA Expands Heart Valve Approval to Include Size for Newborn Patients FDA Expands Heart Valve Approval to Include Size for Newborn Patients
    AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System
    FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit
    Qosina Announces Scott Herskovitz as New President and Chief Executive Officer Qosina Announces Scott Herskovitz as New President and Chief Executive Officer

    Related Breaking News

    • Private Equity Group to Buy Medline for Over $30B

      Private Equity Group to Buy Medline for Over $30B

      Medline will remain a privately held, family-led company.
      Sam Brusco, Associate Editor 06.07.21

    • Diagnostics
      Imec Developing Five Minute COVID Test

      Imec Developing Five Minute COVID Test

      Approach will use virus particles in exhaled breath to identify positive cases and confirm contagion risk.
      Imec 10.30.20

    • Abbott

      Abbott

      ...
      07.21.20


    • Medical Devices and the Political Climate of 2018: An Update from the Swamp

      Medical Devices and the Political Climate of 2018: An Update from the Swamp

      ...
      Jeffrey J. Kimbell and David C. Rudloff, Jeffrey J. Kimbell & Associates Inc. 05.03.18

    • Medtech M&A Off to a Strong Start in 2018

      Medtech M&A Off to a Strong Start in 2018

      ...
      Mark Bonifacio, President, Bonifacio Consulting Services 05.03.18

    Loading, Please Wait..

    Trending
    • Victoria Carr-Brendel Joins Vicarious Surgical Board
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    • The Future Of Biomedical Engineering Advancements
    • Ancora Heart's AccuCinch System Shows Promising Results In Heart Failure Patients
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    Breaking News
    • First European Use of CairnSurgical's Breast Cancer Locator System
    • Healthcare AI Specialist, SensorsCall Join Forces on Home Monitoring Tech
    • Victoria Carr-Brendel Joins Vicarious Surgical Board
    • Cognito Therapeutics raises $73M in Series B Funding for Alzheimer’s Treatment
    • Ancora Heart's AccuCinch System Shows Promising Results in Heart Failure Patients
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Sensing Technology Drives the Future of Medical Care
    • New and Developing Diabetes Technologies Offer 'Sweet Relief'
    • Discussing Matters of Substance in Medtech Materials
    • Medical Device Testers Are Caught Up in a Whirlwind
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOOD Meat Receives FDA Go-Ahead for Cultured Meat
    IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain
    Jones Healthcare Group Primed to Help Nutraceutical Brands Comply with New Packaging Rules
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Wins Three AMPP Awards
    OQ Chemicals Reduces CO2 Emissions at Bay City, Texas Plant by 10% in 2022
    Perstorp Strengthens Sustainable Offerings
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    First European Use of CairnSurgical's Breast Cancer Locator System
    Healthcare AI Specialist, SensorsCall Join Forces on Home Monitoring Tech
    Victoria Carr-Brendel Joins Vicarious Surgical Board
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Aenova Names Roel de Nobel Head of Business Unit Solids
    Macomics, Ono Pharmaceutical Partner to Develop Immuno-oncology Antibody Drugs
    Dupixent Trial Demonstrates Potential to be First Biologic to Treat COPD
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The RealReal Discontinues Beauty Business
    Tree Hut Announces Pop-Up Experience in NYC
    Puig’s Net Revenue Grows 40% to Over $3.9 Billion in 2022
    Happi

    Latest Breaking News From Happi

    Using Green Propolis To Remineralize Teeth
    Mary Kay's Topical with Vinca Major Provides Reduction of Melanin Production
    Gojo Industries Announces Next Phase of its Sustainable Value Strategy
    Ink World

    Latest Breaking News From Ink World

    Amcor, Nfinite Enter into Agreement on Recyclable Packaging
    Smurfit Kappa Completes Exit from Russia
    Sun Chemical Announces Plans for INFOFLEX 2023
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI announces 2022 Eugene Singer Award winners
    Pulse Roll Label Products expands technical sales team
    Mark Andy introduces ProWORX Label Suite
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Heartland Polymers Begins Production in Alberta
    Zeta Polimeri Becomes Radici EcoMaterials
    Responsible Flushing Alliance Holds Annual Meeting
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    3D LifePrints Rebrands to Insight Surgery & Launches New Business in Houston
    Companion Spine Closes $60.1 Million Series A Funding Round
    Missouri Neurosurgeon Settles Federal Kickback Lawsuit for $825K
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    HID Reports on Reshaping the Security Industry
    Meyers Introduces New Function47 Division
    Global Fab Equipment Spending on Track for 2024 Recovery: SEMI

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login